Argos Therapeutics Forecast and Stock Analysis
Technical ARGS stock analysis for April 25, 2019.
|Shorts||0.94% ( 2018-03-29 )|
No changes to the price of Argos Therapeutics in the last trading day. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
Close price at the end of the last trading day (Thursday, 25th Apr 2019) of the ARGS stock was $0.08.
During day the stock fluctuated 29.03% from a day low at $0.06 to a day high of $0.08.
30 day high of the ARGS stock price was $0.09 and low was $0.06.
90 day high was $0.09 and low was $0.05.
52 week high for the Argos Therapeutics - $0.29 and low - $0.02.
Argos Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.26% during the next 3 months and, with 90% probability hold a price between $0.07 and $0.11 at the end of this period.
A buy signal was issued from a pivot bottom point on Monday April 08, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Argos Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.08 and $0.08. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 33 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $0.07 and $0.07.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Argos Therapeutics finds support just below today's level at $0.07. If this is broken, then the next support from accumulated volume will be at $0.07 and $0.06.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Argos Therapeutics stock holds several negative signals and despite the positive trend we believe Argos Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ARGS $0.08 ($0.00 0.00%)|
ARGS is down $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ARGS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ARGS analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us